FDA warns on abortion pill infection risk

Share this article:
The FDA warned doctors yesterday to be on the lookout for rare but deadly bacterial infections in women using Danco Laboratories' abortion pill RU-486.
The warning stated that four women have died from sepsis, an infection of the bloodstream, following use of the drug, also known as Mifeprex.
Although all of the cases were reported in California and involve the off-label use of the drug, the FDA is asking all doctors to look for the symptoms of the infection while the agency reviews the cases.
 
Share this article:

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.